Hearts and bones: Shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development

Developmental Biology

Volumn 294, Issue 2, 2006, Pages 292-302

  Lincoln, Joy ^a   Lange, Alexander W ^a   Yutzey, Katherine E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bone; Cartilage; Disease; Extracellular matrix; Heart; Tendon; Valve

Indexed keywords

AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; CATHEPSIN K; OSTEOCLAST DIFFERENTIATION FACTOR; SCLEROPROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SOX9;

BONE DEVELOPMENT; BONE TISSUE; CARTILAGE; CELL TYPE; CONNECTIVE TISSUE; CONNECTIVE TISSUE DISEASE; HEART; HEART VALVE; HEART VENTRICLE REMODELING; NONHUMAN; PRIORITY JOURNAL; REVIEW; TENDON; VALVULAR HEART DISEASE;

EID: 33745102721     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2006.03.027     Document Type: Review

References (144)

1. Ahmad N.N., Ala-Kokko L., Knowlton R.G., Jimenez S.A., Weaver E.J., Maguire J.I., Tasman W., and Prockop D.J. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6624-6627
2. Ahmad N.N., Richardson J.A., Murfett H.C., Shapiro L., Scott J.D., Yates J.R., Norton J., and Snead M.P. Prevalence of mitral valve prolapse in Stickler syndrome. Am. J. Med. Gen. 116 (2003) 234-237
3. Akhtar S., Meek K.M., and James V. Ultrastructure abnormalities in proteoglycans, collagen fibrils, and elastic fibers in normal and myxomatous mitral valve chordae tendineae. Cardiovasc. Pathol. 8 (1999) 191-201
4. Akiyama H., Chaboissier M.-C., Martin J.F., Schedl A., and de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16 (2002) 2813-2828
5. Akiyama H., Chaboissier M.-C., Behringer R.R., Rowitch D.H., Schedl A., Epstein J.A., and de Crombrugghe B. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 6502-6507
6. Araki T., Mohi M.G., Ismat F.A., Bronson R.T., Williams I.R., Kutok J.L., Yang W., Pao L.I., Gilliland D.G., Epstein J.A., and Neel B.G. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med. 10 (2004) 849-857
7. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R., and Yamada Y. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23 (1999) 354-358
8. Armstrong E.J., and Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 95 (2004) 459-470
9. Barth P.J., Koster H., and Moosdorf R. CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol. Res. Pract. 201 (2005) 301-304
10. Beis D., Bartman T., Jin S., Scott I.C., D'Amico L.A., Ober E.A., Verkade H., Frantsve J., Field H.A., Wehman A., Baier H., Tallafuss A., Bally-Cuif L., Chen J.N., Stainier D.Y.R., and Jungblut B. Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development. Development 132 (2005) 4193-4204
11. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., Sham M.H., Koopman P., Tam P.P., and Cheah K.S. SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16 (1997) 174-178
12. Bi W., Deng J.M., Zhang Z., Behringer R.R., and de Crombrugghe B. Sox9 is required for cartilage formation. Nat. Genet. 22 (1999) 85-89
13. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., and de Crombrugghe B. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6698-6703
14. Birk D.E. Localization of collagen types I, III and V during tendon development. Changes in collagen types I and III are correlated with changes in fibril diameter. Eur. J. Cell Biol. 72 (1997) 352-361
15. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
16. Brent A.E., and Tabin C.J. Developmental regulation of somite derivatives: muscle, cartilage and tendon. Curr. Opin. Genet. Dev. 12 (2002) 548-557
17. Brent A.E., and Tabin C.J. FGF acts directly on the somitic tendon progenitors through the Ets transcription factors Pea3 and Erm to regulate scleraxis expression. Development 131 (2004) 3885-3896
18. Bridgewater L.C., Lefebvre V., and de Crombrugghe B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J. Biol. Chem. 273 (1998) 14998-15006
19. Brown O.R., DeMots H., Kloster F.E., Roberts A., Menashe V.D., and Beals R.K. Aortic root dilatation and mitral valve prolapse in Marfan's syndrome: an ECHOCARDIOgraphic study. Circulation 53 (1975) 651-657
20. Brown D., Wagner D., Li X., Richardson J.A., and Olson E.N. Dual role of the basic helix-loop-helix transcription factor scleraxis in mesoderm formation and chondrogenesis during mouse embryogenesis. Development 126 (1999) 4317-4329
21. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., Scully S., Tan H.L., Xu W., Lacey D.L., Boyle W.J., and Simonet W.S. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12 (1998) 1260-1268
22. Burch G.H., Gong Y., Liu W., Dettman R.W., Curry C.J., Miller W.L., and Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet. 17 (1997) 104-108
23. Capdevila J., and Johnson R.L. Endogenous and ectopic expression of noggin suggests a conserved mechanism for regulation of BMP function during limb and somite patterning. Dev. Biol. 197 (1998) 205-217
24. Chien K.R., and Karsenty G. Longevity and lineages: toward integrative biology of degenerative diseases in heart, muscle, and bone. Cell 120 (2005) 533-544
25. Chimal-Monroy J., Rodriquez-Leon J., Montero J.A., Ganan Y., Macias D., Merino R., and Hurle J.M. Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: sox genes and BMP signaling. Dev. Biol. 257 (2003) 292-301
26. Chiquet M., and Fambrough D.M. Chick myotendinous antigen: I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J. Cell Biol. 98 (1984) 1926-1936
27. Costell M., Carmona R., Gustafsson E., Gonzalez-Iriarte M., Fassler R., and Munoz-Chapuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 91 (2002) 158-164
28. Cripe L., Andelfinger G., Martin L.J., Shooner K., and Benson D.W. Bicuspid aortic valve is heritable. J. Am. Coll. Cardiol. 44 (2004) 138-143
29. de Lange F.J., Moorman A.F.M., Anderson R.H., Manner J., Soufan A.T., de Gier-deVries C., Schneider M.D., Webb S., Van Den Hoff M.J., and Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves. Circ. Res. 95 (2004) 645-654
30. de la Pompa J.L., Timmerman L.A., Takimoto H., Yoshida H., Elia A.J., Samper E., Potter J., Wakeham A., Marengere L., Langille B.L., Crabtree G.R., and Mak T.W. Role of NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392 (1998) 182-186
31. Delot E.C. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol. Genet. Metab. 80 (2003) 27-35
32. Dietz H.C., Loeys B., Carta L., and Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am. J. Med. Genet. 139C (2005) 4-9
33. Dreger S.A., Taylor P.M., Allen S.P., and Yacoub M. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J. Heart Valve Dis. 11 (2002) 875-880
34. Edom-Vovard F., and Duprez D. Signals regulating tendon formation during chick embryonic development. Dev. Dyn. 229 (2004) 449-457
35. Edom-Vovard F., Schuler B., Bonnin M.A., Teillet M.A., and Duprez D. Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons. Dev. Biol. 247 (2002) 351-366
36. Eisenberg L.M., and Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77 (1995) 1-6
37. Ewart A.K., Morris C.A., Atkinson D., Jin W., Sternes K., Spallone P., Stock A.D., Leppert M., and Keating M.T. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat. Genet. 5 (1993) 11-16
38. Ewart A.K., Morris C.A., Ensing G.J., Loker J., Moore C., Leppert M., and Keating M.T. A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 3226-3230
39. Faivre L., Gorin R.J., Wirtz M.K., Godfrey M., Dagoneau N., Samples J.R., Le Merrer M., Collod-Beroud G., Boileau C., Munnich A., and Cirmier-Daire V. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J. Med. Genet. 40 (2003) 34-36
40. Fondard O., Detaint D., Iung B., Choqueux C., Adle-Biassette H., Jarraya M., Hvass U., Couetil J.P., Henin D., Michel J.B., Vahanian A., and Jacob M.P. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur. Heart J. 26 (2005) 1333-1341
41. Foster J.W., Dominguez-Steglich M.A., Guioli S., Kwok C., Weller P.A., Stevanovic M., Weissenbach J., Mansour S., Young I.D., Goodfellow P.N., Brook J.D., and Shafer A.J. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372 (1994) 525-530
42. Garcia-Martinez V., Sanchez-Quintana D., and Hurle J.M. Histochemical and ultrastructural changes in the extracellular matrix of the developing chick semilunar heart valves. Acta Anat. 142 (1991) 87-96
43. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., and Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 437 (2005) 270-274
44. Gelb B.D., Shi G.-P., Chapman H.A., and Desnick R.J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273 (1996) 1236-1238
45. Gitler A.D., Lu M.M., Jiang Y.Q., Epstein J.A., and Gruber P.J. Molecular markers of cardiac endocardial cushion development. Dev. Dyn. 228 (2003) 643-650
46. Gitler A.D., Zhu Y., Ismat F.A., Lu M.M., Yamauchi Y., Parada L.F., and Epstein J.A. Nf1 has an essential role in endothelial cells. Nat. Genet. 33 (2003) 75-79
47. Gleghorn L., Ramesar R., Beighton P., and Wallis G. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am. J. Hum. Genet. 77 (2005) 484-490
48. Glesby M.J., and Pyeritz R.E. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA 262 (1989) 523-528
49. Gowen M., Lazner F., Dodds R., Kapadia R., Feild J., Tavaria M., Bertoncello I., Drake F., Zavarselk S., Tellis I., Hertzog P., Debouck C., and Kola I. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J. Bone Miner. Res. 14 (1999) 1654-1663
50. Griffith A.J., Sprunger L.K., Sirko-Osadsa D.A., Tiller G.E., Meisler M.H., and Warman M.L. Marshall syndrome associated with a splicing defect at the COL11A1 locus. Am. J. Hum. Genet. 62 (1998) 816-823
51. Gross L., and Kugel M.A. Topographic anatomy and histology of the valves in the human heart. Am. J. Pathol. 7 (1931) 445-456
52. Handler M., Yurchenco P.D., and Iozzo R.V. Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 210 (1997) 130-145
53. Henderson D.J., and Cobb A.J. Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ. Res. 83 (1998) 523-532
54. Hirotani H., Tuohy N.A., Woo J.T., Stern P.H., and Clipstone N.A. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J. Biol. Chem. 279 (2004) 13984-13992
55. Hoffman J.I.E., and Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39 (2002) 1890-1900
56. Hurle J.M., Hinchcliffe J.R., Ros M.A., Critchlow M., and Genis-Galvez J.M. The extracellular matrix architecture relating to myotendinous pattern formation in the distal part of the developing chick limb: an ultrastructural, histochemical and immunocytochemical analysis. Cell Differ. Dev. 27 (1989) 103-120
57. Hurle J.M., Kitten G.T., Sakai L.Y., Volpin D., and Solursh M. Elastic extracellular matrix of the embryonic chick heart: an immunohistological study using laser confocal microscopy. Dev. Dyn. 200 (1994) 321-332
58. Icardo J.M., and Colvee E. Atrioventricular valves of the mouse: III. Collagenous skeleton and myotendinous junction. Anat. Rec. 243 (1995) 367-375
59. Ikeda F., Nishimura R., Matsubara T., Tanaka S., Inoue J., Reddy S.V., Hata K., Yamashita K., Hiraga T., Watanabe T., Kukita T., Yoshioka K., Rao A., and Yoneda T. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114 (2004) 475-484
60. Karabagli H., Karabagli P., Ladher R.K., and Schoenwolf G.C. Survey of fibroblastic growth factor expression during chick organogenesis. Anat. Rec. 268 (2002) 1-6
61. Kardon G. Muscle and tendon morphogenesis in the avian hind limb. Development 125 (1998) 4029-4032
62. Karsenty G., and Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2 (2002) 389-406
63. Kielty C.M., Raghunath M., Siracusa L.D., Sherratt M.J., Peters R., Shuttleworth C.A., and Jimenez S.A. The tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils. J. Cell. Biochem. 140 (1998) 1159-1166
64. Kielty C.M., Sherratt M.J., and Shuttleworth C.A. Elastic fibres. J. Cell. Sci. 115 (2002) 2817-2828
65. Kist R., Schrewe H., Balling R., and Scherer G. Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. Genesis 32 (2002) 121-123
66. Klewer S.E., Krob S.L., Kolker S.J., and Kitten G.T. Expression of type VI collagen in the developing mouse heart. Dev. Dyn. 211 (1998) 248-255
67. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Monrony S., Oliveira-dos-Santos A.J., CVan G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., and Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
68. Kou I., and Ikegawa S. SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. J. Biol. Chem. 279 (2004) 50942-50948
69. Krenz M., Yutzey K.E., and Robbins J. The Noonan syndrome mutation Q79R in Shp-2 increases proliferation of valve primordia mesenchymal cells via ERK1/2 signaling. Circ. Res. 97 (2005) 813-820
70. Lange A.W., and Yutzey K.E. NFATc1 expression in the developing valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K. Dev. Biol. 292 (2006) 407-417
71. Laurent S., Boutouyrie P., and Lacolley P. Structural and genetic basis of arterial stiffness. Hypertension 45 (2005) 1050-1055
72. Lee B., Vissing H., Ramirez F., Rogers D., and Rimoin D. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia. Science 244 (1989) 978-980
73. Lee B., Godfrey M., Vitale E., Hori H., Mattei M.G., Safarazi M., Tsipouras P., Ramirez F., and Hollister D.W. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352 (1991) 330-334
74. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., and de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell. Biol. 17 (1997) 2336-2346
75. Li Y., Lacerda D.A., Warman M.L., Beier D.R., Yoshioka H., Ninomiya J., Oxford J.T., Morris N.P., Andrikopoulos K., Ramirez F., Wardell B.B., Lifferth G.D., Teuscher C., Woodward S.R., Taylor B.A., Seegmiller R.E., and Olsen B.R. A fibrillar collagen gene. Col11a1, is essential for skeletal morphogenesis. Cell 80 (1995) 423-430
76. Li D.Y., Faury G., Taylor D.G., Davis E.C., Boyle W.A., Mecham R.P., Stenzel P., Boak B., and Keating M.T. Novel arterial pathology in mice and humans hemizygous for elastin. J. Clin. Invest. 102 (1998) 1783-1787
77. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., McCabe S., Elliott R., Scully S., Van G., Kaufman S., Juan S.C., Sun Y., Tarpley J., Martin L., Christensen K., McCabe J., Kostenuik P., Hsu H., Fletcher F., Dunstan C.R., Lacey D.L., and Boyle W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1566-1571
78. Liao J., and Vesely I. Relationship between collagen fibrils, glycosaminoglycans, and stress relaxation in mitral valve chordae tendineae. Ann. Biomed. Eng. 32 (2004) 977-983
79. Liberatore C.M., and Yutzey K.E. MAP kinase activation in avian cardiovascular development. Dev. Dyn. 230 (2004) 773-780
80. Liberfarb R.M., and Goldblatt A. Prevalence of mitral-valve prolapse in the Stickler syndrome. Am. J. Med. Gen. 24 (1986) 387-392
81. Lincoln J., Alfieri C.M., and Yutzey K.E. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev. Dyn. 230 (2004) 239-250
82. Lincoln J., Alfieri C.M., and Yutzey K.E. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev. Biol. 292 (2006) 290-302
83. Liu X., Wu H., Byrne M., Krane S., and Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1852-1856
84. Liu Y., Li H., Tanaka K., Tsumaki N., and Yamada Y. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J. Biol. Chem. 275 (2000) 12712-12718
85. Lohler J., Timpl R., and Jaenisch R. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell 38 (1984) 597-607
86. Ma L., Lu M.F., Schwartz R.J., and Martin J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132 (2005) 5601-5611
87. Markwald R.R., Fitzharris T.P., and Manasek F.J. Structure and development of endocardial cushions. Am. J. Anat. 148 (1977) 85-120
88. Matsumoto M., Kogawa M., Wada S., Takayanagi H., Tsujimoto M., Katayama S., Hisatake K., and Nogi Y. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 279 (2004) 45969-45979
89. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., Sato Y., Nakagawa N., Yasuda H., Mochizuki S., Gomibuchi T., Yano K., Shima N., Washida N., Tsuda E., Morinaga T., Higashio K., and Ozawa H. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun. 247 (1998) 610-615
90. Mjaatvedt C.H., Yamamura H., Capehart A.A., Turner D., and Markwald R.R. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 202 (1998) 56-66
91. Mohler E.R., Cannon F., Reynolds C., Zimmerman R., Keane M.G., and Kaplan F.S. Bone formation and inflammation in cardiac valves. Circulation 103 (2001) 1522-1528
92. Montero J.A., Giron B., Arrechedera H., Cheng Y.C., Scotting P., Chimal-Monroy J., Garcia-Porrero J.A., and Hurle J.M. Expression of Sox8, Sox9 and Sox10 in the developing valves and autonomic nerves of the embryonic heart. Mech. Dev. 118 (2002) 199-202
93. Morris C.A., Thomas I.T., and Greenberg F. Williams syndrome: autosomal dominant inheritance. Am. J. Med. Gen. 47 (1993) 478-481
94. Nasuti J.F., Zhang P.J., Feldman M.D., Pasha T., Khurana J.S., Gorman J.H., Gorman R.C., Narula J., and Narula N. Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann. Thorac. Surg. 77 (2004) 532-536
95. Ng L.J., Wheatley S., Muscat G.E., Conway-Campbell J., Bowles J.E., Bell D.M., Tam P.P., Cheah K.S., and Koopman P. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183 (1997) 108-121
96. Ng C.M., Cheng A., Myers L.A., Martinez-Murillo F., Jie C., Bedja D., Garielson K.L., Hausladen J.M.W., Mecham R.P., Judge D.P., and Dietz H.C. TGF-β-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J. Clin. Invest. 114 (2004) 1586-1592
97. Nicole S., Davoine C.-S., Topaloglu H., Cattolico L., Barral D., Beighton P., Ben Hamida C., Hammouda H., Cruaud C., White P.S., Samson D., Urtizbera J.A., Lehmann-Horn F., Weissenbach J., Hentati F., and Fontaine B. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat. Genet. 26 (2000) 480-483
98. Nuytinck L., Freund M., Lagae L., Pierard G.E., Hermann-Le T., and De Paepe A. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am. J. Hum. Genet. 66 (2000) 1398-1402
99. Person A.D., Klewer S.E., and Runyan R.B. Cell biology of cardiac cushion development. Int. Rev. Cyt. 243 (2005) 287-335
100. Poole A.R., Kojima T., Yasuda T., Mwale F., Kobayashi M., and Laverty S. Composition and structure of articular cartilage: a template for tissue repair. Clin. Orthop. Relat. Res. 391 (2001) S26-S33 (Suppl.)
101. Rabkin E., Aikawa M., Stone J.R., Fukumoto Y., Libby P., and Schoen F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104 (2001) 2525-2532
102. Rabkin-Aikawa E., Mayer J.E.J., and Schoen F.J. Heart valve regeneration. Adv. Biochem. Eng. Biotechnol. 94 (2005) 141-179
103. Rajamannan N.M., Subramaniam M., Rickard D., Stock S.R., Donovan J., Springett M., Orszulak T., Fullerton D.A., Tajik A.J., Bonow R.O., and Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107 (2003) 2181-2184
104. Ranger A.M., Grusby M.J., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., and Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392 (1998) 186-190
105. Ros M.A., Rivero F.B., Hinchcliffe J.R., and Hurle J.M. Immunohistological and ultrastructural study of the developing tendons of the avian foot. Anat. Embryol. (Berl.) 192 (1995) 483-496
106. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., Moritz J.D., Schu P., and von Figura K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13453-13458
107. Schalkwijk J., Zweers M.C., Steijlen P.M., Dean W.B., Taylor G., van Vlijmen I.M., van Haren B., Miller W.L., and Bristow J. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N. Engl. J. Med. 345 (2001) 1167-1175
108. Schoen F.J. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J. Heart Valve Dis. 6 (1997) 1-6
109. Schoen F.J. Cardiac valves and valvular pathology: update on function, disease, repair and replacement. Cardiovasc. Pathol. 14 (2005) 189-194
110. Schroeder J.A., Jackson L.F., Lee D.C., and Camenisch T.D. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J. Mol. Med. 81 (2003) 392-403
111. Schweitzer R., Chyung J.H., Murtaugh L.C., Brent A.E., Rosen V., Olson E.N., Lassar A., and Tabin C.J. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128 (2001) 3855-3866
112. Scott M., and Vesely I. Aortic valve cusp microstructure: the role of elastin. Ann. Thorac. Surg. 60 (1995) S391-S394
113. Silver F.H., Ebrahimi A., and Snowhill P.B. Viscoelastic properties of self-assembled type I collagen fibers: molecular basis of elastic and viscous behaviors. Connect. Tissue Res. 43 (2002) 569-580
114. Smith T.G., Sweetman D., Patterson M., Keyse S.M., and Munsterberg A. Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite. Development 132 (2005) 1305-1314
115. Snead M.P., Payne S.J., Barton D.E., Yates J.R., al-Imara L., Pope F.M., and Scott J.D. Stickler syndrome: correlation between vitreoretinal phenotypes and linkage to COL 2A1. Eye 8 (1994) 609-614
116. Snead M.P., Yates J.R., Williams R., Payne S.J., Pope F.M., and Scott J.D. Stickler syndrome type 2 and linkage to the COL11A1 gene. Ann. N. Y. Acad. Sci. 785 (1996) 331-332
117. Soini Y., Satta J., Maatta M., and Autio-Harmainen H. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J. Pathol. 194 (2001) 225-231
118. Sugi Y., Ito N., Szebenyi G., Myers K., Fallon J.F., Mikawa T., and Markwald R.R. Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev. Biol. 258 (2003) 252-263
119. Sugi Y., Yamamura H., Okagawa H., and Markwald R.R. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev. Biol. 269 (2004) 505-518
120. Superti-Furga A., Gugler E., Gitzelmann R., and Steinmann B. Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen. J. Biol. Chem. 263 (1988) 6226-6232
121. Supino P.G., Borer J.S., Yin A., Dillingham E., and McClymont W. The epidemiology of valvular heart diseases: the problem is growing. Adv. Cardiol. 41 (2004) 9-15
122. Sykes B., Smith R., Vipond S., Paterson C., Cheah K.S., and Solomon E. Exclusion of the alpha 1(II) cartilage collagen gene as the mutant locus in type IA osteogenesis imperfecta. J. Med. Genet. 22 (1985) 187-191
123. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., and Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3 (2002) 889-901
124. Tamura K., Fukuda Y., Ishizaki M., Masuda Y., Yamanaka N., and Ferrans V.J. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am. Heart J. 129 (1995) 1149-1158
125. Tartaglia M., Mehler E.L., Goldberg R., Zampino G., Brunner H.G., Kremer H., van der Burgt I., Crosby A.H., Ion A., Jeffery S., Kalidas K., Patton M.A., Kucherlapati R.S., and Gelb B.D. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29 (2001) 465-468
126. Theoleyre S., Wittrant Y., Tat S.K., Fortun Y., Redini F., and Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 15 (2004) 457-475
127. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z., Flegal K., ODonnell C., Kittner S., et al. Heart disease and stroke statistics-2006 update. A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 113 (2006) e85-e151
128. Tickle C. Molecular basis of vertebrate limb patterning. Am. J. Med. Gen. 112 (2002) 250-255
129. Tsipouras P., Myers J.C., Ramirez F., and Prockop D.J. Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta. J. Clin. Invest. 72 (1983) 1262-1267
130. Vandenberg P., Khillan J.S., Prockop D.J., Helminen H., Kontussaari S., and Ala-Kokko L. Expression of a partially deleted gene of a human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 7640-7644
131. Vesely I. The role of elastin in aortic valve mechanics. J. Biomech. 31 (1998) 115-123
132. Vesely I. Heart valve tissue engineering. Circ. Res. 97 (2005) 743-755
133. Vissing H., D'Alessio M., MLee B., Ramirez F., Godfrey M., and Hollister D.W. Glycine to serine substitution in the triple helical domain of pro-alpha-1(II) collagen results in a lethal perinatal form of short-limbed dwarfism. J. Biol. Chem. 264 (1989) 18265-18267
134. Walker G.A., Masters K.S., Shah D.N., Anseth K.S., and Leinwand L.A. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ. Res. 95 (2004) 253-260
135. Walsh E.C., and Stainier D.Y.R. UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 293 (2001) 1670-1673
136. Watanabe H., and Yamada Y. Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nat. Genet. 21 (1999) 225-229
137. Watanabe H., Nakata K., Kimata K., Nakanishi I., and Yamada Y. Dwarfism and age-associated spinal degeneration of heterozygote cmd mice defective in aggrecan. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6943-6947
138. Weyman A.E., and Scherrer-Crosbie M. Marfan syndrome and mitral valve prolapse. J. Clin. Invest. 114 (2004) 1543-1546
139. Williams D.R., Presar A.R., Richmond A.T., Mjaatvedt C.H., Hoffman S., and Capehart A.A. Limb chondrogenesis is compromised in the versican deficient hdf mouse. Biochem. Biophys. Res. Commun. 334 (2005) 960-966
140. Yoon S.B., and Lyons K. Multiple functions of BMPs in chondrogenesis. J. Cell. Biochem. 93 (2004) 93-103
141. Yoshioka H., Iyama K.-I., Inoguchi K., Khaleduzzaman M., Ninomiya Y., and Ramirez F. Developmental pattern of expression of the mouse alpha-1(XI) collagen gene (Col11a1). Dev. Dyn. 204 (1995) 41-47
142. Yutzey K.E., Colbert M.C., and Robbins J. Ras-related signaling pathways in valve development: Ebb and flow. Physiology 20 (2005) 390-397
143. Zhang M.C., He L., Giro M., Yong S.L., Tiller G.E., and Davidson J.M. Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN). J. Biol. Chem. 274 (1999) 981-986
144. Zhang G., Young B.B., Ezura Y., Favata M., Soslowsky L.J., Chakravarti S., and Birk D.E. Development of tendon structure and function: regulation of collagen fibrillogenesis. J. Musculoskelet. Neuronal Interact. 5 (2005) 5-21